MARY MANKEY: Open Payments
NPI 1578589453 · PERRY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 48 payments from 15 companies in 2025. Trend: 2023 $497 · 2024 $490 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $203 |
| Axsome Therapeutics, Inc. | 6 | $186 |
| AstraZeneca Pharmaceuticals LP | 7 | $174 |
| Novo Nordisk Inc | 11 | $143 |
| PFIZER INC. | 3 | $56 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Abbott Laboratories | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: CAPLYTA, Auvelity, AIRSUPRA, FARXIGA, Wegovy, Ozempic, NURTEC ODT, MOUNJARO.
Industry payments across MI — which companies pay providers there.
